Reuters AlertNet Lite - World's poor still deprived of drugs -activists

Reuters AlertNet Full site

NEWSDESK

World's poor still deprived of drugs -activists

14 Nov 2006 00:01:00 GMT
Source: Reuters

Previous | Next

A girl queues for anti-tuberculosis drugs at the Blue house clinic, run by medical charity Medecins Sans Frontieres, in the Mathare valley slums of Kenya's capital Nairobi.
REUTERS/Thomas Mukoya

LONDON, Nov 14 (Reuters) - Poor people in developing countries are still not getting access to many life-saving medicines five years after a trade declaration that rich countries should put patients before profits, campaigners said on Tuesday.

British-based anti-poverty charity Oxfam and AIDS groups said rich nations were taking little or no action towards meeting their obligations under the "Doha Declaration", leaving millions without affordable drugs.

The World Trade Organisation granted a special exemption in 2001 allowing countries to put public health ahead of patents within its Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement.

But Oxfam said rich countries, particularly the United States, were bullying developing countries to impose stricter patent rules in order to preserve pharmaceutical monopolies.

Health activists say that access to cheap generic drugs is vital if poor countries are going to put up an effective fight against killer diseases such as AIDS and malaria.

"At the time, the Doha Declaration seemed like a great breakthrough for people in poor countries who urgently needed affordable treatment. Sadly, promising words have not translated into life-saving treatments," said Steve Cockburn, Stop AIDS campaign co-ordinator.

The clash over patents in the developing world has focused attention on a couple of high-profile cases including a dispute over the cancer drug Glivec, made by Switzerland's Novartis <NOVN.VX>.

An Indian court in January rejected its patent application for Glivec, but Novartis is fighting back, arguing that the principle of intellectual property protection must be protected if innovation is to flourish.

The ruling has minimal commercial significance because 99 percent of Indian patients are entitled to receive the drug free of charge under a Novartis compassionate use programme.

But Paul Herrling, the company's head of corporate research, told the Reuters Health Summit last week that India risked falling behind China in drug research if it did not shore up its weak patent protection system.

AlertNet news is provided by

Email this article Send comments

Countries

Small country map
© 2004 Europa Technologies Ltd.

Reset map

• India profile
· View map

MORE >>

NGO latest

• Brighton exhibition to highlight unheard voices from the HIV epidemic for World AIDS Day
International HIV/AIDS Alliance - UK

• Stern figures don't add up for world's poor say Christian Aid
Christian Aid - UK

• STERN TEST FOR WORLD LEADERS ON CLIMATE CHANGE
Christian Aid - UK

• Agency calls for new Millennium Development Goal on Climate Change
Christian Aid - UK

• ACT Rapid Response Payment: West Bengal Cyclone, India
ACT - Switzerland

MORE >>

Latest news

• Villagers worship Indian infant as Mother Goddess

• Global warming could cause bird extinctions-WWF

• Anti-terror panel in focus at India-Pakistan talks

• FACTBOX-Limited progress in India, Pakistan peace talks

• CHRONOLOGY-Peace moves between India and Pakistan

MORE >>

Last updated:Tue Nov 14 08:59:36 2006